{"id":255377,"date":"2024-02-05T00:00:00","date_gmt":"2024-02-05T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/exincg0023-2024-biopharma-epilepsy-executive-insights-dravet-syndrome\/"},"modified":"2026-04-14T10:16:10","modified_gmt":"2026-04-14T10:16:10","slug":"exincg0023-2024-biopharma-epilepsy-executive-insights-dravet-syndrome-executive-insights-us","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/exincg0023-2024-biopharma-epilepsy-executive-insights-dravet-syndrome-executive-insights-us\/","title":{"rendered":"Epilepsy – Executive Insights – Dravet Syndrome | Executive Insights | US"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-255377","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-epilepsy","biopharma-therapy-areas-neurology","biopharma-geography-us","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/255377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/255377\/revisions"}],"predecessor-version":[{"id":281179,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/255377\/revisions\/281179"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=255377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}